Population-based incidence and comparative demographics of community-associated and healthcare-associated Escherichia coli bloodstream infection in Auckland, New Zealand, 2005 – 2011

Clinical and Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in New Zealand: Rapid Emergence of Sequence Type 5 (ST5)-SCCmec-IV as the Dominant Community-Associated MRSA Clone

(2013) Deborah A. Williamson et al.   PLoS One

Impact of ethnicity and socio-economic status on Staphylococcus aureus bacteremia incidence and mortality: a heavy burden in Indigenous Australians

(2012) Steven Y C Tong et al.   BMC INFECTIOUS DISEASES

Escherichia coli Bloodstream Infection After Transrectal Ultrasound-Guided Prostate Biopsy: Implications of Fluoroquinolone-Resistant Sequence Type 131 as a Major Causative Pathogen

(2012) D. A. Williamson et al.   CLINICAL INFECTIOUS DISEASES

Population-based burden of bloodstream infections in Finland

(2012) K. Skogberg et al.   CLINICAL MICROBIOLOGY AND INFECTION

Population-based laboratory assessment of the burden of community-onset bloodstream infection in Victoria, Canada

(2012) K. B. LAUPLAND et al.   EPIDEMIOLOGY AND INFECTION

Identification and molecular characterisation of New Delhi metallo-β-lactamase-1 (NDM-1)- and NDM-6-producing Enterobacteriaceae from New Zealand hospitals

(2012) Deborah A. Williamson et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Increasing incidence of Escherichia coli bacteraemia is driven by an increase in antibiotic-resistant isolates: electronic database study in Oxfordshire 1999-2011

(2012) I. Schlackow et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Increasing incidence of serious infectious diseases and inequalities in New Zealand: a national epidemiological study

(2012) Michael G Baker et al.   LANCET

Is Escherichia coli bacteraemia preventable?

(2012) Mark Melzer et al.   LANCET INFECTIOUS DISEASES

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

(2011) A.-P. Magiorakos et al.   CLINICAL MICROBIOLOGY AND INFECTION

Intercontinental transfer of OXA-181-producing Klebsiella pneumoniae into New Zealand

(2011) D. A. Williamson et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Epidemiology and Risk Factors of Community Onset Infections Caused by Extended-Spectrum  -Lactamase-Producing Escherichia coli Strains

(2011) C.-I. Kang et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Mortality and associated risk factors in consecutive patients admitted to a UK NHS trust with community acquired bacteraemia

(2011) L. Hounsom et al.   POSTGRADUATE MEDICAL JOURNAL

Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand

(2011) Richard Arnold et al.   VACCINE

Costs of Bloodstream Infections Caused by Escherichia coli and Influence of Extended-Spectrum- -Lactamase Production and Inadequate Initial Antibiotic Therapy

(2010) M. Tumbarello et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region

(2008) K.B. Laupland et al.   CLINICAL MICROBIOLOGY AND INFECTION

Socioeconomic risk factors for bacteraemic pneumococcal pneumonia in adults

(2008) J. H. FLORY et al.   EPIDEMIOLOGY AND INFECTION